SARS-CoV-2 takes the bait: Exosomes as endogenous decoys.

Published in: PLoS biology (2022)

Writing in PLOS Biology, Ching and colleagues show that ACE2-decorated exosomes are deployed as natural inhibitory decoys against SARS-CoV-2. High decoy levels correlate with improved patient outcomes, suggesting they directly help COVID-19 recovery and supporting the concept of successful future decoy-based therapies.

Keyphrases

sars cov
mesenchymal stem cells
respiratory syndrome coronavirus
stem cells
current status
angiotensin ii
angiotensin converting enzyme
reduced graphene oxide
bone marrow